Quipt Home Medical Secures Final Court Approval for All-Cash Acquisition; Delisting Expected by March 16

summarizeSummary

Quipt Home Medical Corp. received final court approval for its all-cash acquisition, with the transaction expected to close by March 16, 2026, leading to the delisting of its shares.

check_boxKey Events

• Final Court Approval Secured

  Quipt Home Medical Corp. obtained a final order from the Supreme Court of British Columbia, approving the previously announced plan of arrangement for its acquisition.

• Acquisition Nears Completion

  This final court order was the last substantive court approval required, following shareholder approval on March 3, 2026, making the all-cash acquisition highly likely to close.

• Expected Closing and Delisting

  The transaction is anticipated to be completed by March 16, 2026, after which Quipt's common shares will be delisted from the Toronto Stock Exchange and Nasdaq Capital Market.

• Cash Consideration for Shareholders

  Shareholders will receive cash consideration of US$3.65 per share upon completion of the arrangement.

auto_awesomeAnalysis

This 8-K filing announces a critical milestone in Quipt Home Medical Corp.'s acquisition by affiliates of Kingswood Capital Management, L.P. and Forager Capital Management, LLC. The company has obtained the final order from the Supreme Court of British Columbia, which was the last substantive court approval required. This follows the overwhelming shareholder approval reported on March 3, 2026, making the acquisition's completion highly probable. The transaction is now expected to close by March 16, 2026, after which Quipt's common shares will be delisted from both the Toronto Stock Exchange and Nasdaq Capital Market. This event provides near-term certainty for shareholders, who will receive US$3.65 per share in cash, effectively concluding the company's public trading life.